Details
Stereochemistry | ACHIRAL |
Molecular Formula | Cl.K |
Molecular Weight | 74.551 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[K+]
InChI
InChIKey=WCUXLLCKKVVCTQ-UHFFFAOYSA-M
InChI=1S/ClH.K/h1H;/q;+1/p-1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Potassium is needed to maintain good health. When potassium level falls below 3.5 mmol/L, Hypokalemia is diagnosed. In case of extremely low level of potassium (lower than 2.5 mmol/L) the following symptoms are appeared: malaise and fatigue. This low level of potassium can lead to severe muscle weakness and paralysis; respiratory failure; intermittent muscle spasms. It is known, foods that are good sources of potassium and low in sodium may reduce the risk of high blood pressure and stroke. Potassium supplementation is also recommended as an adjuvant antihypertensive agent for patients with essential hypertension.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Mineral and water nutrition. | 1991 Jul |
|
Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. | 1991 May 15 |
|
Diet, genetics and hypertension. | 1997 Aug |
|
Delay of natural bone loss by higher intakes of specific minerals and vitamins. | 2001 May |
|
Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism. | 2003 Feb 14 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:24:16 GMT 2025
by
admin
on
Mon Mar 31 21:24:16 GMT 2025
|
Record UNII |
660YQ98I10
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 184.1622
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
26.1
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-ATC |
B05XA01
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-VATC |
QA12BA01
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
JECFA EVALUATION |
INS-508
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
NCI_THESAURUS |
C29730
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-VATC |
QB05XA01
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
CFR |
21 CFR 216.24
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
DSLD |
2903 (Number of products:117)
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-ATC |
A12BA01
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
EPA PESTICIDE CODE |
13904
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
403513
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
26.2
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
FDA ORPHAN DRUG |
616817
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-VATC |
QA12BA51
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
WHO-ATC |
A12BA51
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-508
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7447-40-7
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
660YQ98I10
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
32588
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
77368
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
231-211-8
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
8591
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | RxNorm | ||
|
C47679
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200731
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
1548190
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
POTASSIUM CHLORIDE
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
660YQ98I10
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
4873
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
POTASSIUM CHLORIDE
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless. Solubility: Soluble in 3 parts of water; practically insoluble in ethanol (~750 g/l) TS. Category: Ionic equilibration agent. Storage: Potassium chloride should be kept in a well-closed container.Labelling. The designation Potassium chloride for parenteral use indicates that the substance complies with the additionalrequirement given at the end of this monograph and may be used for parenteral administration or for other sterile applications. Definition: Potassium chloride contains not less than 99.0% and not more than 100.5% of KCl, calculated with reference to thedried substance. | ||
|
100000091807
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
SUB12559MIG
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
DB00761
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
DTXSID5021178
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
m9012
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | Merck Index | ||
|
Potassium chloride (medical use)
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
1252
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
D011189
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY | |||
|
4199
Created by
admin on Mon Mar 31 21:24:16 GMT 2025 , Edited by admin on Mon Mar 31 21:24:16 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Route of Elimination | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
SERUM POTASSIUM GREATER THAN 2.5 mEq/L: 200 mEq PER 24 HOURS |
|
||